SENSEX NIFTY
Ranbaxy Laboratories Yearly Results, Ranbaxy Laboratories Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Yearly Results - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 28, 12:55
581.85
-0.95 (-0.16%)
VOLUME 54,928
LIVE
NSE
Jul 28, 12:55
581.70
-1.4 (-0.24%)
VOLUME 448,246
Download Annual Report PDF Format 2014 | 2011 | 2010

Yearly Results of Ranbaxy Laboratories

------------------- in Rs. Cr. -------------------
Dec '13 Dec '12 Dec '11 Dec '10 Dec '09
Net Sales/Income from operations 5,432.45 6,112.44 7,475.90 5,672.10 4,782.76
Other Operating Income 180.47 191.10 214.23 -- --
Total Income From Operations 5,612.92 6,303.54 7,690.12 5,672.10 4,782.76
EXPENDITURE
Consumption of Raw Materials 1,670.46 1,528.66 1,885.10 1,680.31 1,602.08
Purchase of Traded Goods 757.87 809.00 636.73 -- --
Increase/Decrease in Stocks -178.41 -49.25 -135.72 -161.43 -35.26
Power & Fuel -- -- -- -- --
Employees Cost 1,048.45 1,019.59 864.79 776.14 728.40
Depreciation 230.19 186.16 274.08 228.35 148.20
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 2,601.37 2,535.05 3,184.23 2,144.20 1,663.65
P/L Before Other Inc. , Int., Excpt. Items & Tax -517.02 274.33 980.91 1,004.53 675.68
Other Income 148.32 239.60 346.26 360.33 276.39
P/L Before Int., Excpt. Items & Tax -368.70 513.92 1,327.17 1,364.85 952.07
Interest 436.20 296.98 603.56 54.19 -109.85
P/L Before Exceptional Items & Tax -804.90 216.94 723.62 1,310.66 1,061.92
Exceptional Items -971.96 -381.23 -3,772.29 -- --
P/L Before Tax -1,776.85 -164.28 -3,048.67 1,310.66 1,061.92
Tax -- -1.94 3.38 416.52 489.93
P/L After Tax from Ordinary Activities -1,776.85 -162.34 -3,052.05 894.14 571.98
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- 254.59 --
Net Profit/(Loss) For the Period -1,776.85 -162.34 -3,052.05 1,148.73 571.98
Equity Share Capital 211.55 211.46 211.00 210.52 210.21
Reserves Excluding Revaluation Reserves -- 1,709.51 1,713.16 4,915.28 3,748.54
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS -42.01 -3.85 -72.42 -- --
Diluted EPS -42.01 -3.85 -72.42 -- --
EPS After Extra Ordinary
Basic EPS -42.01 -3.85 -72.42 -- --
Diluted EPS -42.01 -3.85 -72.42 -- --
Public Share Holding
No Of Shares (Crores) 14.80 14.52 14.58 14.60 14.62
Share Holding (%) 34.93 34.34 34.56 34.68 34.78
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 26.87 26.87 26.87 -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 -- --
- Per. of shares (as a % of the total Share Cap. of the company) 63.41 63.54 63.68 -- --
Notes Notes To The Accounts
Source : Dion Global Solutions Limited
Quick Links for ranbaxylaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.